Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.
about
Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniaeDaptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsA new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infectionsNovel classes of antibiotics or more of the same?In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.The evaluation and treatment of complicated skin and skin structure infections.Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis.Resistance profiles in surgical-site infection.Are glycopeptides still appropriate and convenient for empiric use?Treatment strategies for central venous catheter infections.Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin.Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.Current and emerging drugs for acute bacterial skin and skin structure infections: an update.Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain.Use of daptomycin in a pregnant patient with Staphylococcus aureus endocarditis.One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces.Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin.Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals.Pharmacokinetics of daily daptomycin in critically ill patients undergoing continuous renal replacement therapy.Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009.Safety of high-dose daptomycin in patients with severe renal impairment.A case report and literature review of daptomycin-induced liver injury
P2860
Q24656785-30DDF6CD-B6C6-4202-96DB-13C09C0A5700Q26752922-1A997544-22DF-4459-9F5D-7552BA6C8BBCQ28474929-77FF5A59-51C7-4C57-B2FB-CAF1F71F5C56Q34903245-92BFF516-204C-4FDB-A8D6-B68EE4E17B3AQ36855598-11B4DFBD-7A0F-4AA7-AF47-0CE21675AF21Q37111836-BD591CA3-498F-4803-A0BE-B5DB9F943A69Q37125518-D9007D39-9BE4-43FE-9B7E-C954B11418BFQ37225677-124E4621-4687-4E50-A0A9-08B1AB33EBE1Q37333194-E9329043-D705-4C87-A645-BF6A640E2D50Q37596412-44F9699C-3CBD-4D8E-836F-2C2C301CC425Q37900838-779AE135-4BAA-4CE0-B03C-D448EA72F438Q38003369-C21B8CD0-5E86-4823-B842-B7784A54838BQ38242081-E82CC007-5111-49DC-AE55-0C1D1547B5BAQ38990504-C9D95DC1-5729-4A67-BEFD-B0C4F2EF99A1Q40364770-64C2B5CB-D36B-4AA4-A424-80408296A67EQ41296754-763BC3AB-7A4A-42A6-A930-B488936E128EQ41884192-D358623A-29EE-4298-B157-D0964AD0DE6CQ43195362-C9CB9942-27CA-475C-90F2-4B95CDF9C05AQ44235973-B6238B6D-0101-4CFE-B7DF-6115E9606DB0Q47828777-B162BA02-AEB6-4513-89FC-A3A083161247Q54120294-AE104A21-4A03-4747-93BA-2BAEAD1F989EQ58775733-F24B45AF-A0B3-4C9E-9507-021B5DF0DE28
P2860
Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Daptomycin: a review of its us ...... hylococcus aureus bacteraemia.
@en
type
label
Daptomycin: a review of its us ...... hylococcus aureus bacteraemia.
@en
prefLabel
Daptomycin: a review of its us ...... hylococcus aureus bacteraemia.
@en
P1433
P1476
Daptomycin: a review of its us ...... hylococcus aureus bacteraemia.
@en
P2093
Philip I Hair
Susan J Keam
P304
P356
10.2165/00003495-200767100-00008
P577
2007-01-01T00:00:00Z
P6179
1001351421